Business & regional news

Comparative data and systematic literature review released at VIVA 2024 show breadth and depth of data supporting atherectomy as a treatment for peripheral arterial disease

Newest-generation Evolut TAVI system builds on its market leading valve performance and durability with enhanced coronary access

Funding to support organisations with a mission to improve health outcomes

The VT research will provide important clinical evidence in an underserved patient population

Survey of 1,000 U.S. surgeons finds digital tech like AI and live streaming crucial to closing surgical care gaps in under-resourced regions.

Global expansion of the Avalus Ultra valve continues in Western Europe while company highlights robust, innovative Cardiac Surgery portfolio at EACTS in Lisbon

Bolsters Medtronic Cardiac Surgery’s comprehensive portfolio of cardiac surgical and respiratory innovation

Company recognized among top 52 global companies making positive social impact through core business strategy

ADAPT-PD trial methods and preliminary data published in npj Parkinson’s disease

Dr. James Porter will represent the company this week — including from the Hugo™ console to perform a live partial nephrectomy — at Europe’s biggest urology conference

Annual award celebrates companies fostering cultures of innovation

State-of-the-art facility based in Singapore aims to accelerate adoption of Robotics and AI across Southeast Asia through training and education, improving access to new healthcare technologies and delivering better care experiences across the region

The company will present clinical evidence in young children, pregnancy and type 2 diabetes*

Post-market data collection will add real-world experience to established safety, efficacy, and efficiency evidence profile

New MRI labeling extends active scan time for Medtronic DBS systems

First ever FDA approval provides more options to meet patients’ personalized needs, including those with Parkinson’s disease

Deal expands Pain Interventions portfolio, now offering both unipedicular and bipedicular vertebral augmentation solutions

New York Valves 2024: Late-breaking data included a SMART Trial secondary analysis showing significantly less bioprosthetic valve dysfunction with Evolut TAV across the entire range of small annulus areas when compared with the Edwards Sapien 3™ TAV platform, and CoreValve-Evolut pooled analysis demonstrating valve performance and durability benefits versus surgery.

Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technology